Prism Medico & Pharmacy Ltd. Press Release Feb 14 2025

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the board of directors at their meeting held today i.e. 14th February 2025 which commenced at 01:30 P.M. and concluded at 05:00 P.M. have inter-alia approved the following: The board considered and approved the Unaudited Standalone financial results of the company for the quarter ended 31st December 2024 along with the Limited Review Report duly signed by the auditors of the company.

View Attachment